Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Dysregulated immune proteins in plasma (SLAMF7, TNFRSF17 (BCMA), QPCT, SLAMF1, CNTN5, BAFF (TNFSF13B)) in the UK Biobank may predict myeloma up to 12 years before clinical diagnosis.”
Title: Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis
Authors: Joshua Fieggen, Anshul Thakur, Christopher C Butler, Karthik Ramasamy, Anjan Thakurta, David A Clifton, Lei Clifton.
Read the Full Article in Blood Advances.
More posts featuring Robert Orlowski.
